Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03085680 · ClinicalTrials.gov registry record · Phase 2

Curcumin and Function in Older Adults

A Phase 2 study of Older Adults and Cognitive Function, sponsored by University of Florida.

Completed
Registry status
Phase 2
Development phase
17
Enrollment target
1
Study location

NCT03085680 is a Phase 2 study of Older Adults and Cognitive Function that has completed, run by University of Florida. The registered enrollment target is 17 participants, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03085680, a Phase 2 study of Older Adults and Cognitive Function, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 2
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

This placebo-controlled RCT tests whether dietary supplementation with curcumin maintains or improves cognitive and physical function in older adults who are at high risk of functional decline due existing (mild) functional impairments and elevated biomarkers of inflammation and explore the association between functional changes and changes in biological indicators of active inflammation.

Interventions

  • DRUG Curcumin
  • DRUG microcrystalline cellulose

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2017-08-11
Est. Completion 2019-10-18
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03085680

The ClinicalTrials.gov registry entry for NCT03085680 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (92% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Older Adults appearing as the primary indexed condition, and to 2 interventions - of which Curcumin is the first listed.

NCT03085680 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03085680 about?

NCT03085680 is a clinical study titled "Curcumin and Function in Older Adults". This placebo-controlled RCT tests whether dietary supplementation with curcumin maintains or improves cognitive and physical function in older adults who are at high risk of functional decline due existing (mild) functional impairments and elevated biomarkers of inflammation and explore the associat...

What is the current status of trial NCT03085680?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2017-08-11. Estimated completion is 2019-10-18.

What conditions does trial NCT03085680 study?

This clinical trial studies the following conditions: Older Adults, Cognitive Function, Physical Function.

What interventions are being tested in trial NCT03085680?

The interventions under investigation include: Curcumin (DRUG), microcrystalline cellulose (DRUG).

Who is sponsoring clinical trial NCT03085680?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03085680 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Older Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.